Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1977 1
1984 1
1990 1
1993 1
1995 1
1996 1
1997 1
1998 1
1999 2
2001 1
2002 1
2004 1
2008 2
2009 1
2010 1
2011 2
2014 1
2015 3
2016 1
2018 1
2019 2
2021 3
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Lip and Oral Cavity Carcinoma"
Page 1
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL. Cohen EEW, et al. J Immunother Cancer. 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5. J Immunother Cancer. 2019. PMID: 31307547 Free PMC article. Clinical Trial.
Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and 380,000 deaths worldwide per annum, and account for over 10,000 annual deaths …
Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal sinuses, oropharynx, …
Head and Neck Cancer Incidence in the United States Before and During the COVID-19 Pandemic.
Semprini J, Pagedar NA, Boakye EA, Osazuwa-Peters N. Semprini J, et al. JAMA Otolaryngol Head Neck Surg. 2024 Mar 1;150(3):193-200. doi: 10.1001/jamaoto.2023.4322. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38206603
DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study of patients in the US diagnosed with HNC from 2017 to 2020, the estimated number with cancer of the oral cavity and pharynx (floor of mouth; gum and other mouth; lip; oropharynx an …
DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study of patients in the US diagnosed with HNC from 2017 to 2020, the estimated n …
Resuming Oral Feeding in Patients With Oral Squamous Cell Carcinoma With Free Anterolateral Thigh Flap Reconstruction.
Chiang TY, Huang CH, Kuan CH, Horng SY, Hsieh JH, Wu YF, Chuang SY, Yu YH, Ho CC, Cheng NC, Tai HC. Chiang TY, et al. Ann Plast Surg. 2021 Feb 1;86(2S Suppl 1):S108-S112. doi: 10.1097/SAP.0000000000002652. Ann Plast Surg. 2021. PMID: 33438960
There was no significant difference in functional recovery between the T&T and non-T&T groups (81.2% vs 73%, P = 0.137). However, among patients who succeeded in resuming oral feeding, lip-sparing patients had better functional recovery in terms of early …
There was no significant difference in functional recovery between the T&T and non-T&T groups (81.2% vs 73%, P = 0.137). However, am …
Lip squamous cell carcinoma in a Brazilian population: epidemiological study and clinicopathological associations.
Souza RL, Fonseca-Fonseca T, Oliveira-Santos CC, Corrêa GT, Santos FB, Cardoso CM, Sant' Ana-Haikal D, Guimarães AL, Batista-De Paula AM. Souza RL, et al. Med Oral Patol Oral Cir Bucal. 2011 Sep 1;16(6):e757-62. doi: 10.4317/medoral.16954. Med Oral Patol Oral Cir Bucal. 2011. PMID: 21196879 Free article.
Data analysis included descriptive statistics and bivariate analyses using the chi-square and Fisher 's exact tests to compare the variables. RESULTS: The LSCC represented 10.8% of all oral cavity squamous cell carcinoma. Lip malignant disease was more …
Data analysis included descriptive statistics and bivariate analyses using the chi-square and Fisher 's exact tests to compare the variables …
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.
Macey R, Walsh T, Brocklehurst P, Kerr AR, Liu JL, Lingen MW, Ogden GR, Warnakulasuriya S, Scully C. Macey R, et al. Cochrane Database Syst Rev. 2015 May 29;2015(5):CD010276. doi: 10.1002/14651858.CD010276.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Jul 20;7:CD010276. doi: 10.1002/14651858.CD010276.pub3. PMID: 26021841 Free PMC article. Updated. Review.
BACKGROUND: Oral squamous cell carcinoma is the most common form of malignancy of the lip and oral cavity, often being proceeded by potentially malignant disorders (PMD). ...PRIMARY OBJECTIVE: To estimate the diagnostic accuracy of index tests f …
BACKGROUND: Oral squamous cell carcinoma is the most common form of malignancy of the lip and oral cavity …
Participation of hypoxia-inducible factor-1alpha and lymphangiogenesis in metastatic and non-metastatic lower lip squamous cell carcinoma.
de Aquino Martins ARL, Santos HBP, Mafra RP, Nonaka CFW, Souza LB, Pinto LP. de Aquino Martins ARL, et al. J Craniomaxillofac Surg. 2018 Oct;46(10):1741-1747. doi: 10.1016/j.jcms.2018.07.020. Epub 2018 Jul 29. J Craniomaxillofac Surg. 2018. PMID: 30119998
This study evaluated the lymphatic density and HIF-1alpha immunoexpression in lower lip squamous cell carcinoma (LLSCC) and their correlation with clinicopathological (nodal metastasis, clinical stage, histological grade, recurrence and disease outcome) and survival …
This study evaluated the lymphatic density and HIF-1alpha immunoexpression in lower lip squamous cell carcinoma (LLSCC) and th …
Classifying pain in transoral endoscopic thyroidectomy.
Zhang D, Caruso E, Sun H, Anuwong A, Tufano R, Materazzi G, Dionigi G, Kim HY. Zhang D, et al. J Endocrinol Invest. 2019 Nov;42(11):1345-1351. doi: 10.1007/s40618-019-01071-0. Epub 2019 Jun 11. J Endocrinol Invest. 2019. PMID: 31187465
Secondary outcome assessed were analgesic rescue dose, morbidity, operative notes, hospital stay, and histopathology. ...Results indicated that TOETVA was associated with reduced neck, cervical back, and swallowing VAS scores in the 24 h after surgery. Conversely, j …
Secondary outcome assessed were analgesic rescue dose, morbidity, operative notes, hospital stay, and histopathology. ...Results indi …
Metastasis of Renal Cell Carcinoma to the Mandible.
Jung SY, Maeng JY, Lee H, Han JJ, Kim SM, Myoung H. Jung SY, et al. J Craniofac Surg. 2023 Jun 1;34(4):e334-e336. doi: 10.1097/SCS.0000000000008985. Epub 2022 Aug 29. J Craniofac Surg. 2023. PMID: 36036497
Given the fact that metastasis of primary neoplasms is not always predictable, it is essential to rule out metastatic carcinoma in jaw lesions. We herein report a rare presentation of metastasis of RCC to the mandible, in which the metastatic lesion in …
Given the fact that metastasis of primary neoplasms is not always predictable, it is essential to rule out metastatic carci …
Association of mast cell, eosinophil leucocyte and microvessel densities in actinic cheilitis and lip squamous cell carcinoma.
Souza LR, Fonseca-Silva T, Santos CC, Oliveira MV, Corrêa-Oliveira R, Guimarães AL, De Paula AM. Souza LR, et al. Histopathology. 2010 Dec;57(6):796-805. doi: 10.1111/j.1365-2559.2010.03721.x. Histopathology. 2010. PMID: 21166694
AIMS: To determine the contributions of mast cells (MC), eosinophil leucocytes (EL) and microvessel density (MVD) in lip carcinogenesis, and to establish the relationships between these biomarkers and their possible prognostic value in lip squamous cell carcinoma …
AIMS: To determine the contributions of mast cells (MC), eosinophil leucocytes (EL) and microvessel density (MVD) in lip carcinogenes …
Cribriform adenocarcinoma of the tongue and minor salivary glands: a systematic review of an uncommon clinicopathological entity.
De Luca P, Tassone D, de Campora L, Simone M, Marra P, Colacurcio V, Scarpa A, Costarelli L, Camaioni A. De Luca P, et al. Eur Arch Otorhinolaryngol. 2022 Jun;279(6):2719-2725. doi: 10.1007/s00405-021-07140-6. Epub 2021 Oct 23. Eur Arch Otorhinolaryngol. 2022. PMID: 34687340 Review.
The most common site of involvement was the tongue (58.9%), followed by palate (19.6%), tonsil (7.1%), buccal (3.6%) and reticular mucosa (3.6%), lip (3.6%), retromolar pad (1.7%), and floor of the mouth (1.7%). ...The results of this review seem to confirm the low …
The most common site of involvement was the tongue (58.9%), followed by palate (19.6%), tonsil (7.1%), buccal (3.6%) and reticular mucosa (3 …
30 results